← Human Trials & Peer-Reviewed Studies

Feeding Patterns of Healthy Term Newborns in the First 5 Days-The Glucose in Well Babies Study (GLOW).

Plain-language guide to PMID 35383475 (2022): observational study of GLOW Blend (GHK-Cu + BPC-157 + TB-500).

Key Facts

PMID
35383475
Journal
Journal of human lactation : official journal of International Lactation Consultant Association
Year
2022
Study type
Observational Study
Authors
Harris DL et al. (3 authors)
DOI
10.1177/08903344221087605

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of GLOW Blend (GHK-Cu + BPC-157 + TB-500), published as an observational study.

To determine the feeding patterns of healthy term newborns soon after birth, and if these differed with sex, gestation, and mode of birth.

Why It Was Studied

The feeding patterns of healthy newborns have been poorly described.

The study protocol is available online: http://hdl.handle.net/2292/32066.

Who Took Part

The age groups tagged for this paper are infants, both men and women.

How the Study Was Run

This study was a prospective, longitudinal observational cohort study.

Term, appropriately grown newborns (N = 66) were fed according to maternal choice and details were recorded.

Data were analyzed using generalized Poisson regression for feeding frequencies, and mixed model regression of log-transformed data for durations.

What Was Measured

Topics PubMed links to this paper include Breast Feeding, Cesarean Section, Glucose, Australia and Feeding Behavior.

Author keywords: breastfeeding, feeding patterns, infant formula, infant health, newborn and observational study.

What This Means in Plain Language

This is an observational study of GLOW Blend (GHK-Cu + BPC-157 + TB-500).

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2022 (Journal of human lactation : official journal of International Lactation Consultant Association), a journal based in United States.

More context: the GLOW Blend (GHK-Cu + BPC-157 + TB-500) compound page, all human trials.

Our Notes on the Compound

GLOW Blend (GHK-Cu + BPC-157 + TB-500): A three-peptide research blend sold in one vial: GHK-Cu, BPC-157 and TB-500. No published human trial has tested the combination.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.